A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-21.57%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$167M
AUM Growth
+$167M
Cap. Flow
+$11.5M
Cap. Flow %
6.88%
Top 10 Hldgs %
98.53%
Holding
14
New
2
Increased
–
Reduced
2
Closed
1

Top Buys

1
EVAR
Lombard Medical, Inc.
EVAR
$25.6M
2
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$56K

Top Sells

1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$7.84M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
$6.26M
3
ZLCS
ZALICUS INC COM NEW
ZLCS
$96K

Sector Composition

1 Healthcare 29.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RNA
1
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$52.4M 31.32% 6,213,924 – –
EVAR
2
DELISTED
Lombard Medical, Inc.
EVAR
$25.6M 15.33% +3,352,544 New +$25.6M
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.53B
$25M 14.96% 2,879,328 -720,672 -20% -$6.26M
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$23.5M 14.07% 930,682 -310,230 -25% -$7.84M
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$15M 8.99% 1,182,196 – –
AMRN
6
Amarin Corp
AMRN
$311M
$8.82M 5.27% 8,087,486 – –
CEMP
7
DELISTED
Cempra, Inc.
CEMP
$7.83M 4.68% 714,285 – –
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
$2.69M 1.61% 2,335,218 – –
RGLS
9
DELISTED
Regulus Therapeutics
RGLS
$2.24M 1.34% 327,350 – –
ACHV icon
10
Achieve Life Sciences
ACHV
$152M
$1.6M 0.96% 603,740 – –
HPTX
11
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.58M 0.94% 62,500 – –
ANTH
12
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$832K 0.5% 437,994 – –
EPRS
13
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$56K 0.03% +7,896 New +$56K
ZLCS
14
DELISTED
ZALICUS INC COM NEW
ZLCS
– – -78,966 Closed -$96K